Trial Information
Detection of Plasma DNA by Allelotyping in Non Small Cell and Small Cell Lung Cancer Patients. Evolution During Treatment and Follow-up.
Inclusion Criteria:
- Presence of lung tumor to use fiberoscopy or surgical intervention for diagnosis.
- No lung instability.
- Individuals give all informed consent
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening
Principal Investigator
Michèle BEAU-FALLER, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Service de Pneumologie, Hôpital de Hautepierre
Authority:
France: Ministry of Health
Study ID:
2731
NCT ID:
NCT00213798
Start Date:
December 2003
Completion Date:
August 2011
Related Keywords:
- Non-Small Cell Lung Carcinoma
- Small Cell Lung Cancer
- Lung cancer
- plasma DNA
- allelotyping
- follow-up
- Prospective Study
- Non-Small Cell Lung Cancer
- Small Cell Lung Cancer
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Small Cell Lung Carcinoma